...
首页> 外文期刊>European heart journal. Acute cardiovascular care >Comparative care and outcomes for acute coronary syndromes in Central and Eastern European Transitional countries: A review of the literature
【24h】

Comparative care and outcomes for acute coronary syndromes in Central and Eastern European Transitional countries: A review of the literature

机译:中欧和东欧转型国家急性冠脉综合征的比较护理和结果:文献综述

获取原文
获取原文并翻译 | 示例
           

摘要

Aims: The purpose of this review was to compare quality of care and outcomes following acute coronary syndrome (ACS) in Central and Eastern European Transitional (CEET) countries.Methods: This was a review of original ACS articles in CEET countries from PubMed, ISI Web of Science, Medline and Embase databases published in English from November 2003 to February 2014. Results: Seventeen manuscripts fulfilled the search criteria. Of 19 CEET countries studied, there were no published ACS management or outcome data for four countries. In-hospital mortality for patients with acute myocardial infarction (AMI) ranged from 6.3% in the Czech Republic to 15.3% in Latvia. In-hospital mortality for ST-elevation myocardial infarction (STEMI) ranged from 3.0% in Poland to 20.7% in Romania. For STEMI, primary percutaneous coronary intervention (PCI) ranged from 1.0% to over 92.0%, fibrinolytic therapy from 0.0% to 49.6%, and no reperfusion therapy from 7.0% to 63.0%.Conclusion: Many CEET countries do not have published ACS care and outcomes data. Of those that do, there is evidence for substantial geographical variation in early mortality. Wide variation in emergency reperfusion strategies for STEMI suggests that acute cardiac care is likely to be modifiable and if addressed could reduce mortality from ACS in CEET countries. The collection of ACS care and outcomes data across Europe must be prioritised.
机译:目的:本综述旨在比较中东欧过渡国家(CEET)国家在急性冠脉综合征(ACS)后的护理质量和结果。方法:本文是对IET PubMed在CEET国家中对ACS原始文章的评论。 2003年11月至2014年2月以英文发布的Web of Science,Medline和Embase数据库。结果:17个手稿满足了搜索条件。在研究的19个CEET国家中,没有四个国家的ACS管理或结果数据发布。急性心肌梗死(AMI)患者的院内死亡率从捷克共和国的6.3%到拉脱维亚的15.3%不等。 ST抬高型心肌梗死(STEMI)的院内死亡率从波兰的3.0%到罗马尼亚的20.7%。对于STEMI,主要经皮冠状动脉介入治疗(PCI)的范围从1.0%至92.0%以上,纤溶疗法的范围从0.0%至49.6%,无再灌注疗法的范围从7.0%至63.0%。结论:许多CEET国家尚未发布ACS护理和结果数据。在这些情况中,有证据表明早期死亡率有很大的地理差异。 STEMI紧急再灌注策略的广泛差异表明,急性心脏护理很可能是可以修改的,如果解决,可以降低CEET国家ACS的死亡率。必须优先考虑整个欧洲ACS护理和结果数据的收集。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号